Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase NA 3Phase 2 1

Status

Completed 5

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 2Tumor-Agnostic 1Genitourinary 1CNS 1

Conditions

Breast Neoplasms 2Prostatic Neoplasms 1Neoplasms 1Brain Neoplasms 1

Interventions

Cyclophosphamide 299Cisplatin 298Paclitaxel 257Radiotherapy 255Fluorouracil 234Carboplatin 234Docetaxel 230Doxorubicin 216Dexamethasone 166Gemcitabine 156Vincristine 147Etoposide 136Leucovorin 133Capecitabine 129Bevacizumab 129Prednisone 125Rituximab 118Methotrexate 118Cytarabine 110Filgrastim 99Trastuzumab 97Oxaliplatin 96pembrolizumab 83Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Daunorubicin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Completed × gadobutrol × Clear all
NCT03404648 2021-02-08

Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI

Mayo Clinic

Phase 3 Completed
19 enrolled 5 charts
Genitourinary

Prostatic Neoplasms

NCT00522951 2017-08-28

SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study

Bayer

Phase 3 Completed
165 enrolled 24 charts
CNS

Brain Neoplasms

NCT01050829 2014-12-30

Gadobutrol Magnevist-controlled Body Study

Bayer

Phase 3 Completed
370 enrolled
Tumor-Agnostic

Neoplasms

NCT01067976 2014-11-11

Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI

Bayer

Phase 3 Completed
446 enrolled 30 charts
Breast

Breast Neoplasms

NCT01104584 2014-11-11

GEMMA 2

Bayer

Phase 3 Completed
460 enrolled 31 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡